1. Home
  2. MGRC vs ARQT Comparison

MGRC vs ARQT Comparison

Compare MGRC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MGRC

McGrath RentCorp

HOLD

Current Price

$118.19

Market Cap

2.8B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$26.21

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGRC
ARQT
Founded
1979
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MGRC
ARQT
Price
$118.19
$26.21
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$141.50
$34.00
AVG Volume (30 Days)
141.3K
1.5M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.67%
N/A
EPS Growth
N/A
88.79
EPS
1.10
N/A
Revenue
$944,235,000.00
$376,072,000.00
Revenue This Year
$4.69
$34.85
Revenue Next Year
$4.81
$29.39
P/E Ratio
$106.58
N/A
Revenue Growth
3.65
91.34
52 Week Low
$94.99
$13.06
52 Week High
$128.41
$31.77

Technical Indicators

Market Signals
Indicator
MGRC
ARQT
Relative Strength Index (RSI) 67.08 71.86
Support Level $106.34 $24.81
Resistance Level $118.28 $27.26
Average True Range (ATR) 2.80 1.09
MACD 0.81 0.56
Stochastic Oscillator 97.64 87.88

Price Performance

Historical Comparison
MGRC
ARQT

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: